The Estée Lauder Companies (NYSE: EL) (the company) is placing renewed emphasis on women’s health with the launch of its 2024 Breast Cancer Campaign, spotlighting a powerful message: Breast Care is Self-Care. The company aims to inspire and educate women across generations to become advocates for their breast health, reframing self-care to include proactive prevention and early detection measures.
The company has been at the forefront of efforts to create a breast cancer-free world since Evelyn H. Lauder co-created the pink ribbon and started The Estée Lauder Companies’ Breast Cancer Campaign (The Campaign) in 1992. Together, The Campaign and The Estée Lauder Companies Charitable Foundation have funded more than $131 million for lifesaving global research, education, and access to medical services with more than $103 million funding medical research through the Breast Cancer Research Foundation.
Talking about breast care as self-care is a natural extension of The Estée Lauder Companies’ long-standing legacy in both breast cancer and beauty. In the U.S., female breast cancer incidence rates have been increasing since the mid-2000s, and in the past decade, the increase in incidence was higher in women under 50.1 Breast Care is Self-Care exemplifies the evolved focus of The Campaign to educate women, particularly younger women, to become advocates for their own breast health.
Breast Care is Self-Care is communicated through a compelling new video and digital campaign. The video features female employees in New York who shared their authentic views on the link between breast health and self-care. The company aims to reshape how women approach self-care, urging them to include breast health as an integral part of their wellness routines.
A dedicated new website centralizes essential tools and resources to understand breast health, including how to recognize potential signs and symptoms of breast cancer and the importance of both screenings and healthy habits. The site encourages women to be proactive about their health, offering information on dense breast tissue, performing self-exams, and accessing a personalized breast cancer risk assessment. To view the video and learn more, visit here.
The 5-year relative survival rate for breast cancer that is detected early, or in its localized stage, is 99%.2 The company hopes that by shifting the conversation around self-care, encouraging individuals to become advocates for their breast health and disrupting expectations in the beauty space, it will reach more women and ultimately save lives.
Through its Breast Cancer Campaign, the company will also:
-
Fund medical research and fellowships worldwide
- In 2022 The Estée Lauder Companies Charitable Foundation made a commitment to donate $15 million over five years to the Breast Cancer Research Foundation, to establish a Health Equity Initiative. This ongoing research will further the goal of reducing breast cancer disparities and improving outcomes in Black women. To learn more, visit here.
- Support 60+ organizations aligned to the diverse needs of local communities
- Support women in science, research and medicine – funding grants and programs around the world and accelerating opportunities for women in STEM
- Fund medical resources and services including access to mammograms/screenings for vulnerable groups with limited access to healthcare
- Host and convene events on breast health education with key opinion leaders and experts
- Engage with a selection of ELC’s iconic brands, each donating to the Breast Cancer Research Foundation and/or local cancer-focused organizations through product sales or flat donations (brand participation varying by market). To learn more, visit here.
- Illuminate buildings, monuments and landmarks around the world in pink to raise awareness, including: Empire State Building, New York City; Eiffel Tower, Paris; Lotte World Tower, Seoul, among others
“Breast cancer remains the most commonly diagnosed cancer in women worldwide3,” said William P. Lauder, Executive Chairman, The Estée Lauder Companies Inc. “We will continue supporting the brilliant researchers who are working towards a cure while also advocating for prevention and early detection. I’m incredibly proud of the meaningful efforts shown by our employees, consumers, and partners, who unite around this shared goal.”
As long as breast cancer is a life-threatening disease, The Estée Lauder Companies’ commitment remains unwavering.
To learn more, visit: ELCompanies.com/BreastCancerCampaign
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
ELC-C
- American Cancer Society Facts & Figures 2022 - 2024
- American Cancer Society Survival Rates for Breast Cancer
- World Health Organization
View source version on businesswire.com: https://www.businesswire.com/news/home/20241001995673/en/
